All In Biotech

Drug Trial Radar · NCT01101438

A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer

A Phase III Randomized Trial of Metformin Versus Placebo on Recurrence and Survival in Early Stage Breast Cancer

Last checked: Nov 19, 2026Latest source record: Sep 13, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 3,649 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

3,649

Actual

Start

Aug 13, 2010

Primary completion

Sep 21, 2021

Study completion Aug 18, 2023

Sponsor

Lead sponsor
Canadian Cancer Trials GroupResearch network
Sponsor type
Research network
Collaborators
National Cancer Institute (NCI); ETOP IBCSG Partners Foundation; Institute of Cancer Research, United Kingdom
First posted
Apr 12, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 74 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is looking at whether Metformin, an agent that is commonly used to treat diabetes, can decrease or affect the ability of breast cancer cells to grow and whether Metformin will work with other therapies to keep cancer from recurring. Health Canada has not approved the sale or use of Metformin to treat breast cancer, although they have approved its use in this clinical trial. Although Metformin is approved by the FDA for the treatment of diabetes, its use in breast cancer is considered investigational.

Conditions

  • Breast Cancer

Interventions

  • metformin hydrochlorideDrug

    Given orally

  • placeboOther

    Given orally

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Invasive Disease-free Survival in Hormone Receptor (ER and PgR) Positive Sub-groupsTime frame: 5 years
  2. Invasive Disease-free SurvivalTime frame: 5 years

Locations

344 sites in 4 countries. Site status is shown where the registry gives one.

  • Providence Alaska Medical Center

    Anchorage, Alaska

  • Fairbanks Memorial Hospital

    Fairbanks, Alaska

  • Pinnacle Oncology Associates

    Scottsdale, Arizona

  • Mayo Clinic in Arizona

    Scottsdale, Arizona

  • Arizona Cancer Center at University Medical Center North

    Tucson, Arizona

  • University of Arizona Health Sciences Center

    Tucson, Arizona

  • Kaiser Permanente-Deer Valley Medical Center

    Antioch, California

  • Alta Bates Summit Medical Center-Herrick Campus

    Berkeley, California

  • Enloe Medical Center

    Chico, California

  • Glendale Memorial Hospital and Health Center

    Glendale, California

  • Kaiser Permanente, Hayward

    Hayward, California

  • Moores University of California San Diego Cancer Center

    La Jolla, California

  • Long Beach Memorial Medical Center-Todd Cancer Institute

    Long Beach, California

  • University of Southern California

    Los Angeles, California

  • University of California at Los Angeles (UCLA )

    Los Angeles, California

  • Fremont - Rideout Cancer Center

    Marysville, California

  • Bay Area Tumor Institution CCOP

    Oakland, California

  • Kaiser Permanente-Oakland

    Oakland, California

  • University of California Medical Center At Irvine-Orange Campus

    Orange, California

  • Pomona Valley Hospital Medical Center

    Pomona, California

  • Kaiser Permanente-Redwood City

    Redwood City, California

  • Kaiser Permanente-Richmond

    Richmond, California

  • Kaiser Permanente-Roseville

    Roseville, California

  • University of California Davis-Cancer Center

    Sacramento, California

  • Kaiser Permanente-South Sacramento

    Sacramento, California

  • Kaiser Permanente - Sacramento

    Sacramento, California

  • Kaiser Permanente-Mission

    San Diego, California

  • Kaiser Permanente

    San Diego, California

  • Kaiser Permanente-San Francisco

    San Francisco, California

  • University of California San Francisco Medical Center-Mount Zion

    San Francisco, California

  • Kaiser Permanente-Santa Teresa-San Jose

    San Jose, California

  • Kaiser Permanente-San Rafael

    San Rafael, California

  • Kaiser Permanente Medical Center - Santa Clara

    Santa Clara, California

  • Kaiser Permanente-Santa Rosa

    Santa Rosa, California

  • Kaiser Permanente-South San Francisco

    South San Francisco, California

  • Stanford University

    Stanford, California

  • Kaiser Permanente-Stockton

    Stockton, California

  • Tahoe Forest Cancer Center

    Truckee, California

  • Kaiser Permanente Medical Center-Vacaville

    Vacaville, California

  • Kaiser Permanente-Vallejo

    Vallejo, California

Showing 40 of 344 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.